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Introduction: Over the past two decades, the study of chronic cocaine and crack cocaine exposure in the
pediatric population has been focused on the potential adverse effects, especially in the prenatal period and early
childhood. Non-invasive biological matrices have become an essential tool for the assessment of a long-term
history of drug of abuse exposure.
Case report: We analyze the significance of different biomarker values in hair after chronic crack exposure in a
two-year-old Caucasian girl and her parents, who are self-reported crack smokers. The level of benzoylecgonine,
the principal metabolite of cocaine, was determined in segmented hair samples (0 cm to 3 cm from the scalp, and
> 3 cm from the scalp) following washing to exclude external contamination. Benzoylecgonine was detectable in
high concentrations in the child’s hair, at 1.9 ng/mg and 7.04 ng/mg, respectively. Benzoylecgonine was also
present in the maternal and paternal hair samples at 7.88 ng/mg and 6.39 ng/mg, and 13.06 ng/mg and 12.97 ng/
mg, respectively.
Conclusion: Based on the data from this case and from previously published poisoning cases, as well as on the
experience of our research group, we conclude that, using similar matrices for the study of chronic drug exposure,
children present with a higher cocaine concentration in hair and they experience more serious deleterious acute
effects, probably due to a different and slower cocaine metabolism. Consequently, children must be not exposed
to secondhand crack smoke under any circumstance.
Introduction
Since the mid-1990s, cocaine has been the second most
popular illegal recreational drug in Europe among
young adults and adolescents, the first being cannabis
[1]. Similar to other illicit drugs, cocaine is commonly
used by different routes of administration: orally, by
smoking or chewing; parenterally; as a suppository; and,
mainly, by snorting or inhalation of crack cocaine
smoke. Free-base crack cocaine is a potent form of
cocaine rapidly absorbed through the pulmonary circu-
lation and reaching the central nervous system within
seconds, which results in rapid and striking stimulant
effects [2]. Its pharmacological action by smoking is
responsible for many of the reported neurological and
pulmonary toxic effects [3,4]. Over the last 20 years,
parallel to the advances in laboratory techniques for
detecting recent drug use, hair analysis has emerged as
the most important non-invasive biomarker used to pro-
vide long-term information on an individual’sd r u gu s e
[5-8]. Decontamination of hair samples by washing
before analysis, detection of the relevant metabolites and
use of adequate cut-off levels have been the main con-
siderations in testing for drugs in hair [9]. The differen-
tiation between systemic exposure and external
contamination has been a controversial topic and one of
the limitations of cocaine testing in hair [10-12]. In fact,
hair exposed to crack cocaine by external contamina-
tion, where the individual does not actively consume the
drug but traces may be deposited on the hair, must be
carefully considered [13]. At present, hair analysis is
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exposure to drugs of abuse [14]. In the pediatric popula-
tion, hair screening has been used to determine gesta-
tional cocaine exposure [15,16], detect unsuspected
exposure to cocaine in children [17,18] and confirm
chronic cocaine exposure in cases of acute intoxication
or high suspicion [19]. Similarly, in adults, cocaine hair
screening is routinely applied to detect drug abuse in
forensic cases, occupational and traffic medicine and
clinical toxicology [14], including monitoring of cocaine-
abusing households by child welfare agencies in child
custody cases.
To the best of our knowledge, there are no previous
publications reporting on biomarker values in children’s
hair after chronic exposure to crack smoke and active
abuse and exposure in adults. Here, we present a case of
chronic exposure to cocaine through passive inhalation
of crack cocaine smoke in a two-year-old girl as result
of suspicion of environmental exposure to this drug of
abuse by a pediatrician.
Case presentation
A two-year-old Caucasian girl was brought to our Pedia-
tric Emergency Department, referred from a pediatric
outpatient center for unclear reasons after presenting
with respiratory symptoms for two weeks. Her medical
r e c o r d ss h o w e dt h a ts h eh a db e e nd i a g n o s e dw i t hn e o -
natal withdrawal syndrome, which required long term
treatment with phenobarbital. At the outpatient center,
she had been diagnosed with repeated bronchiolitis and
she needed health care services from a pediatric pulmo-
nologist, who prescribed treatment with fluticasone. She
had no other relevant medical or pathological
background.
Medical records informed us that the child’sm o t h e r
had a medical history of substance-related disorders and
she was receiving treatment for heroin dependence with
methadone. No other pharmacological treatment was
prescribed for cannabis and tobacco abuse.
When attending our department, the mother pre-
sented an unhealthy aspect and abnormal behavior. A
physical examination of the child showed a minor
asthma attack with respiratory difficulties and clinical
features refractory to the outpatient bronchodilator
treatment (salbutamol) over the past 15 days. The exam-
ination also revealed use of her accessory muscles for
respiration, wheezing and bilateral hypoventilation. Her
blood oxygen saturation level was 98% and cyanosis was
not observed. Her vital signs revealed tachycardia and
tachypnea without fever (her heart rate was 148 beats
per minute, her respiratory rate, 60 breaths per minute
and temperature 36°C). A neurological examination did
not show a focal neurological deficit (15/15 Glasgow
Score Scale) and the remainder of the physical
examination was normal. The child received respiratory
support and pharmacological treatment with gradual
clinical improvement. Her blood cell count and serum
biochemistry were normal. Under suspicion of exposure
to drugs of abuse, urinary toxicology screening for com-
monly used drugs of abuse by cloned enzyme donor
immunoassay (CEDIA, Microgenics, Barcelona, Spain)
was done. Repeated urinary tests were positive for
cocaine. Since urine toxicology was done in a pediatric
emergency ward and speed was of paramount impor-
tance, the level of benzoylecgonine (BZG) in her urine
was not quantified.
Information concerning the environment where the
child had been living was obtained from the mother,
who confirmed a history of crack smoking by both par-
ents in the presence of the child during the days pre-
vious to her hospital admission. She denied that her
child had ingested cocaine by any other route than pas-
sive inhalation. Chronic exposure to cocaine in an envir-
onment where drugs of abuse were being used by the
parents was verified by hair analysis for the child and
her parents (Table 1).
After 48 hours, our patient recovered completely with-
out any respiratory difficulties. She was discharged from
the hospital and the proper authorities were alerted in
order to evaluate the child’s home conditions.
In the present case, a quantitative analysis of cocaine,
opiates, amphetamines, cannabis and 3,4-methylenediox-
ymethamphetamine (MDMA) in her hair was performed
according to forensic standards using an immunoassay
(VMA/DRI
®) on the available length of hair. The child’s
and her parent’s hair samples (as an entire strand) were
cut close to the scalp at the vertex region using stainless
steel scissors. Whenever possible (hair shaft length more
than 3 cm), the hair strands were divided into subse-
quent 3 cm segments, each representing hair growth in
subsequent three-month periods. To exclude external
contamination, the samples were washed before testing.
A comprehensive toxicological screening was per-
formed on the collected hair samples. The test was posi-
tive for BZG, the main metabolite of cocaine, and
cannabis in the entire hair samples. Quantitative analysis
c o n f i r m e dt h a tB Z Gw a sp r e s e n ti nt h ec h i l d ’sh a i ra ta
concentration of 1.9 ng/mg and 7.04 ng/mg. BZG con-
centrations found in her mother’s and father’sh a i rw e r e
7.88 ng/mg and 6.39 ng/mg, and 13.06 ng/mg and 12.97
ng/mg, respectively. Opiates were detected in her
mother’s hair. Amphetamines and MDMA were not
detected.
Discussion
The information regarding passive postnatal toxic
exposure to cocaine in children is limited. At our hos-
pital, hair analysis in preschool children without signs
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mated prevalence of exposure of 23.3% [17]. There are
several clinical case reports detailing concentrations of
BZG in the hair of children with parents using
cocaine who are exposed to a contaminated
environment, with considerable clinical findings (neu-
rological and respiratory abnormalities), fatal poison-
ings by active ingestion (by hand-to-mouth activity) of
powder residues [20,21] or passive crack smoke inha-
lation [22-24].
Table 1 Hair segment concentration of drugs of abuse from the child and her parents using VMA/DRI
®.
Hair segments Drugs of abuse and metabolites in hair (cut off values)
BZG (0.50 ng/mg) Cannabis (0.10 ng/mg) Opiates (0.50 ng/mg)
Child’s hair
0 cm to 3 cm 1.9 0.3 ND
> 3 cm 7.04 0.7 ND
Mother’s hair
0 cm to 3 cm 7.88 0.92 13.88
> 3 cm 6.39 0.94 3.15
Father’s hair
0 cm to 3 cm 13.06 0.28 ND
> 3 cm 12.97 0.86 ND
BZG: benzoylecgonine; ND: none detected
Table 2 Cases reports of acute intoxication in children exposed passively to cocaine and confirmed by hair analysis.
Age Chronic exposure Benzoylecgonine in hair determined by gas chromatography/mass spectrometry (GC/MS) (ng/mg)
[25] 11 months Cocaine Infant’s hair
1 cm to 4 cm: 0.4
4 cm to 8 cm: 10.5
Mother’s hair
1 cm to 10 cm: negative for any illicit substance (bleached hair)
[26] 15 months Cocaine Infant’s hair
1 cm to 2 cm: 2.2
2 cm to 7 cm: 7.6
Sister’s hair
1 cm to 2 cm: negative
2 cm to 7 cm: 0.5
7 cm to 20 cm: 1.2
Mother’s hair
1 cm to 2 cm: 8.2
2 cm to 7 cm: 5.3
7 cm to 20 cm: 10.6
Father’s hair
1 cm to 2 cm: 3.0
[27] 24 months Infant’s hair
0 cm to 1 cm: 1.9
1 cm to 15 cm: 17.2
a
[28] 13 months Cocaine Infant’s hair
0.6







Papaseit et al. Journal of Medical Case Reports 2011, 5:570
http://www.jmedicalcasereports.com/content/5/1/570
Page 3 of 5In this case report the appearance of the family and
their medical records, in addition to the clinical features
presented by the child, suggested the possibility of an
unhealthy environment and consequently intoxication
with drugs of abuse. Her exposure to cocaine in the days
preceding her admission was confirmed by an initial
positive urinary immunoassay, in addition to symptoms
suggesting recent exposure to crack cocaine smoke.
Under the circumstances, analysis of the child’sa n d
parent’s hair was performed in order to assess previous
and chronic exposure to cocaine and other illicit drugs
(the clinical consequences of a polyexposure can be very
serious). The BZG concentrations found in the proximal
and distal extremities of our patient’s hair demonstrated
repeated exposure to environmental cocaine at least
during the last three months. Therefore, the need to be
admitted at the pediatric emergency, the medical back-
ground of the child and the presence of BZG in her hair
can be all explained by a systematic passive exposure to
crack cocaine smoke. The BZG concentration in her
hair was proportionally higher than the BZG concentra-
tion in her parent’s hair, who actively smoked crack
cocaine. Considering this child’s age, the results suggest
that passive environmental exposure in young children
may have highly toxic, even potential lethal, effects,
probably due to their immature metabolizing capacity.
In fact, previous cases of symptomatic chronic intoxica-
tion by cocaine have been described, but with lower
concentration of cocaine in hair in comparison with
adult hair concentrations [25-29].
Based on the data from this case and other poisoning
cases published by our group and other groups (Table
2) [25-29], we conclude that parental use of cocaine can
be reflected in a non-negligible exposure of their pro-
geny, and children show higher concentrations of
cocaine in hair and they experience more serious dele-
terious acute effects, perhaps due to different and slower
cocaine metabolism.
Conclusion
We conclude that passive exposure to smoked cocaine
must be strictly avoided in infants and children. In addi-
tion, drug testing in conventional (urine and blood) and
non-conventional (hair) matrices should be used routinely
in all the children who present with specific or suspicious
symptoms of acute and/or chronic exposure to illicit
drugs, particularly with suspected drug-using parents, fre-
quently polyusers. Once again, hair analysis proved to be a
useful tool in disclosing chronic exposure to drugs of
abuse. Furthermore, hair analysis offers the opportunity to
periodically examine drug exposure in order to protect
these children from significant health and social risks. We
advocate hair analysis in all cases of newborns, toddlers
and children from risky environments.
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